However, as explained above, GLP-1Rs are not only localized to organs involved in the glycemic response, such as the pancreas and the liver, but are also expressed in various regions of the brain through neurons and glial cells [108]
Meanwhile, more than 12% of patients on the highest dose also experienced dysesthesia, which is an unpleasant nerve sensation observed in previous trials of the drug
This website is for browsing only
In post hoc analyses at 24 weeks, those switching from Wegovy to orforglipron saw a weight change of -0.1 kg, compared to a 9.4 kg gain in the placebo group
The addition of glucagon receptor activation in retatrutide, combined with GIP, creates a metabolic environment that simultaneously improves insulin sensitivity, enhances appropriate insulin secretion, and increases energy expenditure
Crucially, this journey extends beyond the plate